← Leaderboards
Benjamin James Frisch
University Of Rochester
$169,294
Attributed
$169,294
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $60K · FY2014–16$100K$75K$50K$25K$0
'14
'15
'16
Funding mix
By agency
NIH$169,294 · 1
By mechanism
F32$169,294 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Rochester
Same institution · by research overlap
- James Palis$20,960,389
- Jeevisha Bajaj$2,438,184
- Allison Jinquan Li$199,104
- Jennifer Anolik$10,004,053
- Kelly McGlynn$132,144
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectGain Of FunctionBaseBcr-Abl Fusion ProteinsAnimalsBiologyBoneBone LossBone MarrowCc Chemokine Receptor 1BiologicalCcr5 GeneCell CountCell LineageCellsCharacteristicsChemokineClinicCoculture TechniquesCytopeniaDefectEnvironmentCcl3 GeneGenetic Models
Grant awards (3)
Molecular Mechanism of Osteoblastic Inhibition in Myeloid Malignancies$59,970
F32 · FY2016 · CA · contact PI
Molecular Mechanism of Osteoblastic Inhibition in Myeloid Malignancies$56,042
F32 · FY2015 · CA · contact PI
Molecular Mechanism of Osteoblastic Inhibition in Myeloid Malignancies$53,282
F32 · FY2014 · CA · contact PI